Stapled antimicrobial peptides (Lytica Therapeutics)

N/A

Report date: 2025/10/31 15:38:14
NME

Base Information

Drug NameStapled antimicrobial peptides (Lytica Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs > AntibioticsSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAcinetobacter Baumannii InfectionsMultidrug-Resistant InfectionPseudomonas Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLytica Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLytica Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMultidrug-Resistant Infection
Inactive IndicationsAcinetobacter Baumannii InfectionsPseudomonas InfectionsGram-Negative Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A